Navigation Links
WuXi PharmaTech Announces Third-Quarter 2013 Results

financial results and future prospects.  The conference call may be accessed by calling:


4001 200 539Hong Kong

800 905 927Singapore

800 616 3222United Kingdom

0800 015 9725United States

1855 298 3404United States - New York (toll)

+1 631 5142 526Other countries (toll)

+65 6823 2299Conference ID

5522969A telephone replay will be available two hours after the call's completion at:


4001 842 240Hong Kong

800 966 697Singapore

800 616 2127United Kingdom

0800 169 7301United States

1866 846 0868Conference ID

5522969A live webcast of the conference call and replay will be available on the investor relations page of WuXi PharmaTech's website at

About WuXi PharmaTechWuXi PharmaTech is a leading pharmaceutical, biotechnology, and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: .

Forward-Looking StatementsThis press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not historical facts, but instead are predictions about future events. Examples of forward-looking statements in this press release include statements about our fourth-quarter and full-year 2013

SOURCE WuXi PharmaTech
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. WuXi PharmaTech Announces Licensing Agreement for Patient-Derived Xenograft Models with Mayo Clinics Center for Individualized Medicine
2. featured expert Kevin Matras highlights: Core Laboratories NV, Invesco Ltd., Medtronic, Inc., Willbros Group Inc. and WuXi PharmaTech Inc.
3. WuXi PharmaTech Schedules First-Quarter 2013 Earnings Release
4. Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules
5. WuXi PharmaTech Receives Letter from AAALAC Commending Animal Care at Suzhou Toxicology Facility as "Exemplary"
6. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2012 Results, Share Repurchase Program
7. WuXi PharmaTech and Open Monoclonal Technology Expand Human Antibody Development and Commercial Opportunities for Asian Regional and Global Pharmaceutical Companies
8. WuXi PharmaTech Schedules Fourth-Quarter 2012 Earnings Release
9. WuXi PharmaTech Presents the 2012 Life Science and Chemistry Awards
10. WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2012 Annual General Meeting
11. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
Post Your Comments:
(Date:10/9/2015)... Maryland , October 9, 2015 ... Inc. (OTCQB: CNBX) has announced its execution of an Intellectual ... & Liabilities Agreement with Cannabics, Inc. a Delaware Corporation, related ... company. --> --> ... restructuring of the Company, whereby the Research and Development ...
(Date:10/9/2015)... DIEGO , Oct. 9, 2015  The ... National Center for Emerging and Zoonotic Infectious Diseases, ... Genome have entered into a research collaboration to ... platform. The goal of this research collaboration is ... DRAGEN platform for public health and infectious disease ...
(Date:10/9/2015)... Oct. 9, 2015   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... Phase 3 clinical study of telotristat etiprate has been accepted ... symposium to be held from October 15-17, in ... patients who completed the randomized treatment portion of the TELESTAR ... poster session. --> --> ...
Breaking Medicine Technology:
... YORK, Dec. 15, 2011  New York University and the ... they have appointed Theodore (Ted) Rappaport, 51, to lead ... Rappaport, currently the William and Bettye ... at Austin (UTA), is a leading educator and entrepreneur ...
... 15, 2011  Today, the Consumer Healthcare Products Association (CHPA), announced ... Five Moms campaign to raise awareness of ... of two teenage boys and a high school math teacher ... the dangers of substance abuse. Millions of ...
Cached Medicine Technology:
(Date:10/9/2015)... LA (PRWEB) , ... October 09, 2015 , ... ... offices serving New Orleans and the surrounding communities, is initiating a combined charity ... medical care for unwanted animals in southern Louisiana. , Animal Rescue New ...
(Date:10/9/2015)... ... October 09, 2015 , ... MMJ PhytoTech Limited ... Ed Begley Jr., airing 1st QT 2016 via the Discovery Channel. Dates and ... Phytotech Limited (MMJ) – a global leader in the field of commercializing medicinal ...
(Date:10/9/2015)... ... 09, 2015 , ... Ryan Fox, the founder and CEO ... Colorado, says the latest figures on the state’s sales of legalized marijuana acknowledge ... industry. , Last month, according to the website , Colorado's ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... Most people ... processed with more vegetables and less meat. While noted T’ai Chi Master and integrative ... “Yin and Yang” relationship between the two cuisines and that they potentially complement one ...
(Date:10/9/2015)... ... , ... A variety of race options will be available for the Run 4 Recovery sponsored ... at Al Lopez Park, 4810 North Himes Avenue, in Tampa. The family friendly event will ... run or walk and a one-mile walk, followed by an award ceremony at 10 a.m. ...
Breaking Medicine News(10 mins):
... Systems, Inc. (MDS), a national leader in accounts receivable management, and ... to the newly created position of Chief Operating Officer (COO). ... ... healthcare receivables industry leader, MDS ( ), has announced Eugene ...
... House made the correct decision to withdraw its ... have military veterans, personal insurance companies pay for ... Ryan, Jr., USN-Ret., president of the Military Officers ... President Obama that "pursuing this insurance proposal would ...
... - Estimated one-year, recurrence-free survival was 98% for Kit-positive ... placebo(1)- Historically, one in two patients experienced recurrence of ... - Gleevec is the only treatment in the US ... GIST after surgery; regulatory review is underway in the ...
... ANN ARBOR, Mich.---Scientists are closer to understanding which proteins ... exercise. This understanding could lead to new drug therapies ... and other health problems associated with having high blood ... by the body doesn,t properly stimulate the transport of ...
... 18 Askesis Development Group, Inc., a leader ... treatment, and social services markets, is pleased to ... enhanced features are focused on creating a completely ... comprehensive electronic medical record (EMR), and streamlined revenue ...
... 18 Bionovo, Inc. (Nasdaq: BNVI ), a ... in women,s health and oncology, today announced that Isaac Cohen, ... Wall Street Analyst Forum,s 20th Annual Institutional Investor Conference at ... will be held at the University Club in New York ...
Cached Medicine News:
... full length 10" elastic binder has a variety ... as an abdominal binder for post-surgical dressings. ... there has been a loss of muscle tone. ... rib belt to prevent painful expansion of the ...
Designed to provide relief from chronic or acute back pain by unloading pressure off the lumbar discs and shifting pressure to the abdominal region...
... consists of an anterior thoracic and pelvic ... serrated discs on the superior and inferior ... uprights are padded and adjustable in length. ... thoracic extensions.,Biomechanics: B.O.S.S. L-25A controls flexion with ...
Effectively stabilize and relax your back with the LumboTrain back support....
Medicine Products: